Core One Labs and Ketamine Infusion Centers to Explore DMT Therapy for Anxiety and Depression
Core One Labs is exploring DMT therapy for anxiety and depression in a partnership with Ketamine Infusion Centers.
Core One Labs is exploring DMT therapy for anxiety and depression in a partnership with Ketamine Infusion Centers.
A new study is looking at how psilocybin treatment may help to reduce debilitating short-lasting unilateral neuralgiform headache attacks.
In this episode, we chat with David Harder, the Co-Founder and CEO of ATMA Journey Centers, about their new healing and training space.
Tony White may have lost his battle with cancer, but becoming the first end of life recipient of psilocybin treatment has changed everything.
New research is looking at psilocybin truffles as a potential anti-aging tool and aid in treating age-related psychiatric disorders.
End of content
End of content
By signing up to the Psychedelic Spotlight newsletter you agree to receive electronic communications from Psychedelic Spotlight that may sometimes include advertisements or sponsored content.